The Online Investor
Home
Dividends
25 Safe Dividends
Stock Splits
Mergers & Acquisitions
Business Services/Equipment M&A

Construction M&A
   General Contractors & Builders M&A
Consumer Goods M&A
   Sporting Goods & Activities M&A
   Office Supplies M&A
   Food & Beverage M&A
   Beverages & Wineries M&A
   Cigarettes & Tobacco M&A
   Marijuana Stocks M&A
   Apparel Stores M&A
   Department Stores M&A
   Grocery & Drug Stores M&A
   Electronics Stores M&A
   Home Improvement Stores M&A
   Home Furnishing Stores M&A
   Auto Dealerships M&A
   Specialty Retail M&A
Consumer Services M&A
   Education & Training Services M&A
Energy M&A
   Oil & Gas Refining & Marketing M&A
   Oil & Gas Exploration & Production M&A
   Oil & Gas Equipment & Services M&A
Financial M&A
   Banking & Savings M&A
   Investment Brokerages M&A
   Investment Companies & Venture Capital M&A
   Asset Management M&A
   Credit Services & Lending M&A
   Life & Health Insurance M&A
   Insurance Brokers M&A
Healthcare M&A
   Drugs & Pharmaceuticals M&A
   Biotechnology M&A
   Diagnostics M&A
   Medical Instruments & Supplies M&A
   Hospital & Medical Practitioners M&A
Industrial M&A
   Chemicals M&A
   Specialty Chemicals M&A
   Defense M&A
   Aerospace & Defense M&A
   Construction Materials & Machinery M&A
   Industrial Machinery & Equipment M&A
Manufacturing M&A
   Home Furnishings & Furniture M&A
   Auto Manufacturers M&A
   Auto Parts M&A
   Textiles & Apparel M&A
Materials M&A
   Agricultural Chemicals M&A
   Rubber & Plastics M&A
   Paper & Forest Products M&A
   Packaging & Containers M&A
   Agriculture & Farm Products M&A
Media M&A
   Advertising M&A
   Television & Radio M&A
   Publishing & Printing M&A
Metals & Mining M&A
   Precious Metals M&A
   Non-Precious Metals & Non-Metallic Mining M&A
   Metals Fabrication & Products M&A
Real Estate M&A
   REITs M&A
Technology M&A
   Electronic Equipment & Products M&A
   3D Printing Stocks M&A
   Computers M&A
   Computer Peripherals M&A
   Application Software M&A
   Semiconductors M&A
   Information Technology Services M&A
Transportation M&A
   Air Services Other M&A
   Airlines M&A
   Trucking M&A
   Shipping M&A
   Railroads M&A
Travel & Entertainment M&A
   Hotels, Lodging, Restaurants & Travel M&A
   Entertainment M&A
Utilities M&A
   Waste Management M&A
   Communications Services M&A
   Electric Utilities M&A
   Gas Utilities M&A
   Water Utilities M&A
Mega Mergers
Daily M&A
Contrarian Outlook
Stock Option Ideas
Preferred Stock Newsletter
ChartZero.com
Stock Buybacks
IPOs
Secondary Offerings
Top 20 Large Caps
Top 20 Biggest ETFs
Insider Buying
Top 25 Low PE Ratios
Analyst Actions
25 Top Analyst Picks
Articles
CAGR Calculator
Dunnan On Dollars
10 Pot Stocks
ETF Center
Knowledge Center
Retirement Center
Advertising Opportunities
Privacy Policy
Disclaimer Statement
Biotechnology M&A image Biotechnology M&A » By The Online Investor Staff, updated Sat., Apr. 27, 8:19 AM Recent mergers and acquisitions in the Biotechnology M&A category.

This Slide: #1 of 83

Slide #1. Telik, Inc. — MabVax Therapeutics, Inc.

Acquirer: Telik, Inc. (TELK)
Acquiree: MabVax Therapeutics, Inc.
Details: Telik, Inc., a clinical stage oncology drug development company, and MabVax Therapeutics, Inc., a privately held cancer immunotherapy company, have entered into a definitive merger agreement. Upon closing of the transaction, MabVax and Telik will be combined into a publicly traded company focused on the development of proprietary immunotherapy-based products to diagnose and treat cancer. Under the terms of the merger agreement, MabVax will merge with a wholly-owned subsidiary of Telik in an all-stock transaction. The boards of directors of both companies have approved the merger and the stockholders of MabVax have also approved the merger. The merger is subject to the approval of the Telik stockholders as well as other customary conditions. Upon the closing of the transaction, Telik will be re-named MabVax Therapeutics Holdings, Inc. and will operate under the leadership of the MabVax management team with J. David Hansen, President and CEO of MabVax, serving as the President, CEO, and Chairman of the Board. Michael M. Wick, M.D., Ph.D., who currently serves as President and CEO of Telik, will remain on the board.

Telik is a clinical-stage drug development company focused on discovering and developing small molecule drugs to treat cancer. TELINTRA, Co.'s lead drug candidate is a small molecule glutathione analog inhibitor of the enzyme glutathione S-transferase P1-1 (GST P1-1). Co. is developing TELINTRA for the treatment of blood disorders that are characterized by defects in blood formation with associated with low blood cell levels, such as anemia or thrombocytopenia. TELCYTA, Co.'s second product candidate, is a small molecule cancer drug designed to be activated in cancer cells.

Open the TELK Page at The Online Investor »

TELK — Key Stats (updated Tue., Jul. 8, 10:23 AM)
Company Name:  Telik Inc
Website:  www.telik.com
Sector:  Biotechnology
 

Open the TELK Page at The Online Investor (in a new window) »

List of Biotechnology Mergers & Acquisitions in this Slideshow:

8/29/2012:
Acquirer: Charles River Laboratories International, Inc. (CRL)
Acquiree: Accugenix, Inc.
Merger/Acquisition details: details »

9/6/2012:
Acquirer: Spectrum Pharmaceuticals (SPPI)
Acquiree: Allos Therapeutics (ALTH)
Merger/Acquisition details: details »

9/13/2012:
Acquirer: Thermo Fisher Scientific Inc. (TMO)
Acquiree: One Lambda, Inc.
Merger/Acquisition details: details »

9/19/2012:
Acquirer: Illumina (ILMN)
Acquiree: BlueGnome Ltd.
Merger/Acquisition details: details »

10/1/2012:
Acquirer: ProStrakan Group plc
Acquiree: GTx, Inc. (GTXI)
Merger/Acquisition details: details »

10/18/2012:
Acquirer: BioCryst Pharmaceuticals, Inc. (BCRX)
Acquiree: Presidio Pharmaceuticals, Inc.
Merger/Acquisition details: details »

10/24/2012:
Acquirer: OpenGate Capital, LLC
Acquiree: Laboratory Workstations Business from Thermo Fisher Scientific Inc. (TMO)
Merger/Acquisition details: details »

11/12/2012:
Acquirer: PerkinElmer (PKI)
Acquiree: Shanghai Haoyuan Biotech Co., Ltd.,
Merger/Acquisition details: details »

12/12/2012:
Acquirer: Gilead Sciences, Inc. (GILD)
Acquiree: YM BioSciences Inc. (YMI)
Merger/Acquisition details: details »

12/17/2012:
Acquirer: Bio-Rad (BIO)
Acquiree: MorphoSys's Research and Diagnostic Antibody Business AbD Serotec
Merger/Acquisition details: details »

12/21/2012:
Acquirer: Acorda Therapeutics, Inc. (ACOR)
Acquiree: Neuronex, Inc.
Merger/Acquisition details: details »

12/27/2012:
Acquirer: PAREXEL International Corporation (PRXL)
Acquiree: Liquent, Inc.
Merger/Acquisition details: details »

1/7/2013:
Acquirer: Illumina, Inc. (ILMN)
Acquiree: Verinata Health, Inc.
Merger/Acquisition details: details »

1/8/2013:
Acquirer: Charles River Laboratories International, Inc. (CRL)
Acquiree: Vital River
Merger/Acquisition details: details »

1/10/2013:
Acquirer: Bio-Rad Laboratories, Inc. (BIO)
Acquiree: AbD Serotec
Merger/Acquisition details: details »

2/4/2013:
Acquirer: ICON plc (ICLR)
Acquiree: Clinical Trial Services Division of Cross Country Healthcare, Inc. (CCRN)
Merger/Acquisition details: details »

2/8/2013:
Acquirer: Gilead Sciences, Inc. (GILD)
Acquiree: YM BioSciences Inc. (YMI)
Merger/Acquisition details: details »

2/21/2013:
Acquirer: Illumina, Inc. (ILMN)
Acquiree: Verinata Health
Merger/Acquisition details: details »

2/25/2013:
Acquirer: Cubist Pharmaceuticals, Inc. (CBST)
Acquiree: Adynxx
Merger/Acquisition details: details »

4/15/2013:
Acquirer: Thermo Fisher Scientific (TMO)
Acquiree: Life Technologies Corporation (LIFE)
Merger/Acquisition details: details »

4/30/2013:
Acquirer: PAREXEL International Corporation (PRXL)
Acquiree: HERON Group LTD
Merger/Acquisition details: details »

6/18/2013:
Acquirer: BELLUS Health Inc. (BLU.CA)
Acquiree: Thallion Pharmaceuticals Inc. (TLN.CA)
Merger/Acquisition details: details »

6/18/2013:
Acquirer: Techne Corporation (TECH)
Acquiree: Bionostics Holdings Limited
Merger/Acquisition details: details »

7/9/2013:
Acquirer: Acorda Therapeutics, Inc. (ACOR)
Acquiree: Two neuropathic pain management assets from NeurogesX, Inc. (NGSX)
Merger/Acquisition details: details »

7/17/2013:
Acquirer: Spectrum Pharmaceuticals (SPPI)
Acquiree: Talon Therapeutics, Inc. (TLON)
Merger/Acquisition details: details »

7/22/2013:
Acquirer: Techne Corporation (TECH)
Acquiree: Bionostics Holdings Limited
Merger/Acquisition details: details »

7/23/2013:
Acquirer: Illumina (ILMN)
Acquiree: Advanced Liquid Logic
Merger/Acquisition details: details »

7/30/2013:
Acquirer: Cubist Pharmaceuticals (CBST)
Acquiree: Trius Therapeutics (TSRX)
Merger/Acquisition details: details »

7/30/2013:
Acquirer: Cubist Pharmaceuticals (CBST)
Acquiree: Optimer Pharmaceuticals (OPTR)
Merger/Acquisition details: details »

8/2/2013:
Acquirer: Emergent BioSolutions Inc. (EBS)
Acquiree: Healthcare Protective Products Division from Bracco Diagnostics Inc.
Merger/Acquisition details: details »

8/15/2013:
Acquirer: BELLUS Health (BLU.CA)
Acquiree: Thallion Pharmaceuticals (TLN.CA)
Merger/Acquisition details: details »

8/21/2013:
Acquirer: Thermo Fisher (TMO)
Acquiree: Life Technologies (LIFE)
Merger/Acquisition details: details »

8/26/2013:
Acquirer: Sangamo BioSciences (SGMO)
Acquiree: Ceregene
Merger/Acquisition details: details »

9/4/2013:
Acquirer: Agilent Technologies Inc. (A)
Acquiree: ABC Instrumentacin Analtica
Merger/Acquisition details: details »

9/10/2013:
Acquirer: Sorrento Therapeutics, Inc. (SRNE)
Acquiree: IgDraSol
Merger/Acquisition details: details »

9/11/2013:
Acquirer: Cubist Pharmaceuticals, Inc. (CBST)
Acquiree: Trius Therapeutics (TSRX)
Merger/Acquisition details: details »

9/16/2013:
Acquirer: Americas Bullion Royalty Corp. (AMB.CA)
Acquiree: EMC Metals Corp. (EMC.CA)
Merger/Acquisition details: details »

10/1/2013:
Acquirer: Asterias Biotherapeutics, Inc (BTX)
Acquiree: Geron's Embryonic Stem Cell Assets
Merger/Acquisition details: details »

10/14/2013:
Acquirer: StoneCalibre
Acquiree: Anatrace, a part of Affymetrix, Inc. (AFFX)
Merger/Acquisition details: details »

10/21/2013:
Acquirer: PDL BioPharma (PDLI)
Acquiree: Type 2 diabetes products licensed by Depomed (DEPO)
Merger/Acquisition details: details »

10/21/2013:
Acquirer: Oxygen Biotherapeutics, Inc. (OXBT)
Acquiree: Certain assets of Phyxius Pharma
Merger/Acquisition details: details »

10/24/2013:
Acquirer: Cubist Pharmaceuticals (CBST)
Acquiree: Optimer Pharmaceuticals (OPTR)
Merger/Acquisition details: details »

10/28/2013:
Acquirer: Illumina, Inc. (ILMN)
Acquiree: NextBio
Merger/Acquisition details: details »

10/29/2013:
Acquirer: StemCells, Inc. (STEM)
Acquiree: Seminal Neural Stem Cell Patent Portfolio
Merger/Acquisition details: details »

11/11/2013:
Acquirer: Grifols (GRFS)
Acquiree: Transfusion diagnostics unit of Novartis (NVS)
Merger/Acquisition details: details »

11/14/2013:
Acquirer: Sorrento Therapeutics, Inc. (SRNE)
Acquiree: Concortis Biosystems, Corp
Merger/Acquisition details: details »

11/14/2013:
Acquirer: Oxygen Biotherapeutics (OXBT)
Acquiree: Phyxius Pharma Assets
Merger/Acquisition details: details »

11/26/2013:
Acquirer: Thermo Fisher Scientific (TMO)
Acquiree: Life Technologies (LIFE)
Merger/Acquisition details: details »

12/12/2013:
Acquirer: Retrophin (RTRX)
Acquiree: Kyalin Biosciences
Merger/Acquisition details: details »

12/12/2013:
Acquirer: Emergent BioSolutions (EBS)
Acquiree: Cangene Corporation (CNJ.CA)
Merger/Acquisition details: details »

12/20/2013:
Acquirer: Sorrento Therapeutics (SRNE)
Acquiree: Concortis Biosystems
Merger/Acquisition details: details »

12/20/2013:
Acquirer: Intrexon (XON)
Acquiree: Medistem (MEDS)
Merger/Acquisition details: details »

1/3/2014:
Acquirer: Americas Bullion Royalty Corp. (AMB.CA)
Acquiree: Springer Mining Company and Nevada Assets
Merger/Acquisition details: details »

1/6/2014:
Acquirer: Americas Bullion Royalty Corp. (AMB.CA)
Acquiree: Assets of Kudu Partners, L.P.
Merger/Acquisition details: details »

1/6/2014:
Acquirer: GE Healthcare (GE)
Acquiree: Thermo Fisher Scientific Cell Culture, Gene Modulation and Magnetic Beads Businesses (TMO)
Merger/Acquisition details: details »

1/13/2014:
Acquirer: Agenus Inc. (AGEN)
Acquiree: 4-Antibody AG
Merger/Acquisition details: details »

1/13/2014:
Acquirer: Galena Biopharma (GALE)
Acquiree: Mills Pharmaceuticals
Merger/Acquisition details: details »

2/4/2014:
Acquirer: Thermo Fisher Scientific (TMO)
Acquiree: Life Technologies Corporation (LIFE)
Merger/Acquisition details: details »

2/4/2014:
Acquirer: Myriad Genetics, Inc. (MYGN)
Acquiree: Crescendo Bioscience
Merger/Acquisition details: details »

2/5/2014:
Acquirer: Myriad Genetics (MYGN)
Acquiree: Crescendo Bioscience
Merger/Acquisition details: details »

2/10/2014:
Acquirer: Mast Therapeutics (MSTX)
Acquiree: Aires Pharmaceuticals, Inc.
Merger/Acquisition details: details »

2/13/2014:
Acquirer: Retrophin (RTRX)
Acquiree: Manchester Pharmaceuticals
Merger/Acquisition details: details »

2/13/2014:
Acquirer: Emergent BioSolutions (EBS)
Acquiree: Cangene Corporation (CNJ)
Merger/Acquisition details: details »

2/13/2014:
Acquirer: Agenus (AGEN)
Acquiree: 4-Antibody
Merger/Acquisition details: details »

2/19/2014:
Acquirer: Emergent BioSolutions Inc. (EBS)
Acquiree: Cangene Corporation (CNJ.CA)
Merger/Acquisition details: details »

2/27/2014:
Acquirer: Mast Therapeutics (MSTX)
Acquiree: Aires Pharmaceuticals, Inc.
Merger/Acquisition details: details »

3/6/2014:
Acquirer: Alnylam Pharmaceuticals, Inc. (ALNY)
Acquiree: Merck's Sirna Therapeutics Subsidiary
Merger/Acquisition details: details »

3/7/2014:
Acquirer: Intrexon Corporation (XON)
Acquiree: Medistem (MEDS)
Merger/Acquisition details: details »

3/13/2014:
Acquirer: Charles River Laboratories (CRL)
Acquiree: CRO Services Division of Galapagos NV
Merger/Acquisition details: details »

3/13/2014:
Acquirer: Intrexon Corporation (XON)
Acquiree: Laboratory Operations from Codexis
Merger/Acquisition details: details »

3/24/2014:
Acquirer: AMRI (AMRI)
Acquiree: Cedarburg Pharmaceuticals, Inc.
Merger/Acquisition details: details »

3/24/2014:
Acquirer: GE Healthcare (GE)
Acquiree: Thermo Fisher Scientific Certain Biosciences Businesses (TMO)
Merger/Acquisition details: details »

3/27/2014:
Acquirer: Retrophin (RTRX)
Acquiree: Manchester Pharmaceuticals
Merger/Acquisition details: details »

3/31/2014:
Acquirer: ICON (ICLR)
Acquiree: Aptiv Solutions
Merger/Acquisition details: details »

4/1/2014:
Acquirer: Charles River Laboratories (CRL)
Acquiree: CRO Services Division of Galapagos NV
Merger/Acquisition details: details »

4/4/2014:
Acquirer: AMRI (AMRI)
Acquiree: Cedarburg Pharmaceuticals, Inc.
Merger/Acquisition details: details »

4/14/2014:
Acquirer: NeoStem (NBS)
Acquiree: California Stem Cell, Inc.
Merger/Acquisition details: details »

4/15/2014:
Acquirer: NeoStem (NBS)
Acquiree: California Stem Cell, Inc.
Merger/Acquisition details: details »

4/21/2014:
Acquirer: Aastrom Biosciences, Inc. (ASTM)
Acquiree: Sanofi's Cell Therapy and Regenerative Medicine Business
Merger/Acquisition details: details »

5/6/2014:
Acquirer: Warnex (WNX.H.CA)
Acquiree: DIAGNOS Inc. (ADK.CA)
Merger/Acquisition details: details »

5/8/2014:
Acquirer: ICON (ICLR)
Acquiree: Aptiv Solutions
Merger/Acquisition details: details »

5/8/2014:
Acquirer: NeoStem, Inc. (NBS)
Acquiree: California Stem Cell, Inc.
Merger/Acquisition details: details »

5/12/2014:
Acquirer: Telik, Inc. (TELK)
Acquiree: MabVax Therapeutics, Inc.
Merger/Acquisition details: details »
April 27, 2024  •  8:19 AM Eastern
TELK — Current Quote
Quotes delayed 20 minutes

Email EnvelopeFree TELK Email Alerts:
Get SEC Filing Alerts
Get Dividend Alerts

Biotechnology M&A | www.TheOnlineInvestor.com | Copyright © 1998 - 2024, All Rights Reserved

Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes, powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.